Arcus Biosciences Long Term Deferred Charges (Quarterly) Analysis

Arcus Biosciences, Inc. (RCUS)

21.01 -0.34 (-1.59%) USD | NYSE | Jan 09, 16:00

21.01 0.00 (0.00%) After-Hours: 17:53

View Long Term Deferred Charges (Quarterly) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	--
Actinium Pharmaceuticals, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
Karyopharm Therapeutics, Inc.	--
Janux Therapeutics, Inc.	--